Ajil Asma
About Ajil Asma
Ajil Asma is a QC Chemist at The Siegfried Group in Wilmington, Delaware, with over 22 years of experience in the pharmaceutical industry, specializing in quality control chemistry. He previously worked at Eurofins in Luxembourg and holds a Bachelor's degree from the University of Kuwait.
Work at The Siegfried Group
Ajil Asma has been employed at The Siegfried Group since 2002, serving as a QC Chemist and Laborantin in Wilmington, Delaware. With over 22 years of experience at the company, Asma plays a key role in quality control chemistry within the pharmaceutical sector. The Siegfried Group operates globally, with facilities in Switzerland, Germany, France, Malta, China, and the USA. Asma is part of a team that focuses on the development and manufacturing of active pharmaceutical ingredients and finished dosage forms, including sterile fillings.
Previous Experience at Eurofins
Before joining The Siegfried Group, Ajil Asma worked at Eurofins as a Laborantin from 2000 to 2002 in Clausen, Luxembourg. This role contributed to Asma's foundational experience in the pharmaceutical industry, specifically in laboratory settings. The two years spent at Eurofins provided valuable insights and skills that have been applied in subsequent positions.
Education and Expertise
Ajil Asma studied at the Universität of Kuwait, where he earned a Bachelor's degree from 1984 to 1990. This educational background laid the groundwork for a career in the pharmaceutical industry, particularly in quality control chemistry. With over two decades of experience, Asma has developed expertise in various aspects of pharmaceutical manufacturing and quality assurance.
Background in Pharmaceutical Industry
With more than 20 years of experience in the pharmaceutical industry, Ajil Asma specializes in quality control chemistry. His career has been dedicated to ensuring the integrity and safety of pharmaceutical products. Asma's work involves contributing to innovative solutions that enhance the value provided to pharmaceutical clients, focusing on both active pharmaceutical ingredients and finished dosage forms.